Article
Systemic ELOVL6 activity predicts survival and represents a modifiable target of ALS
2026-05-03
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Amyotrophic lateral sclerosis (ALS) is characterized by profound metabolic reprogramming, yet the lack of biomarkers for specific druggable targets remains a major hurdle for precision medicine. We hypothesized that peripheral lipid biosynthetic signatures could serve as both prognostic indicators and a roadmap for identifying novel disease-modifying targets. <h4>Methods</h4...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 744da1c4-302c-56ce-a880-21ed4b16517b
- DOI
- 10.64898/2026.04.30.26352060
